Author:
El-Soussi Sarra,Hanna Reine,Semaan Hanna,Khater Amanda-Rose,Abdallah Jad,Abou-Kheir Wassim,Abou-Antoun Tamara
Abstract
Neuroblastoma is the most common extracranial nervous system tumor in children. It presents with a spectrum of clinical prognostic measures ranging from benign growths that regress spontaneously to highly malignant, treatment evasive tumors affiliated with increased mortality rates. MYCN amplification is commonly seen in high-risk neuroblastoma, rendering it highly malignant and recurrence prone. In our current study, we investigated the therapeutic potential of small molecule inducers of TRAIL, ONC201, and ONC206 in MYCN-amplified IMR-32 and non-MYCN-amplified SK-N-SH human neuroblastoma cell lines. Our results exhibit potent antitumor activity of ONC201 and ONC206 via a novel inhibition of EGF-induced L1CAM and PDGFRβ phosphorylation in both cell lines. Drug treatment significantly reduced cellular proliferation, viability, migration, invasion, tumorsphere formation potential, and increased apoptosis in both cell lines. The protein expression of tumorigenic NMYC, Sox-2, Oct-4, FABP5, and HMGA1 significantly decreased 48 h post-drug treatment, whereas cleaved PARP1/caspase-3 and γH2AX increased 72 h post-drug treatment, compared with vehicle-treated cells in the MYCN-amplified IMR-32 cell line. We are the first to report this novel differential protein expression after ONC201 or ONC206 treatment in human neuroblastoma cells, demonstrating an important multitarget effect which may yield added therapeutic benefits in treating this devastating childhood cancer.
Subject
Pediatrics, Perinatology and Child Health
Reference59 articles.
1. Neuroblastoma;Matthay;Nat Rev Dis Prim.,2016
2. Neuroblastoma: molecular pathogenesis and therapy;Louis;Annu Rev Med.,2015
3. The epidemiology of neuroblastoma: a review;Heck;Paediatr Perinat Epidemiol.,2009
4. Overview and recent advances in the treatment of neuroblastoma;Whittle;Expert Rev Anticancer Ther.,2017
5. Neuroblastoma;Davidoff;Semin Pediatr Surg.,2012
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献